NCT04778735

Brief Summary

The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
207

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

February 24, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2022

Completed
Last Updated

April 6, 2022

Status Verified

February 1, 2021

Enrollment Period

1.1 years

First QC Date

February 24, 2021

Last Update Submit

April 4, 2022

Conditions

Liver TransplantationLiver DiseasesBiliary AtresiaMorbidity;InfantMortality

Outcome Measures

Primary Outcomes (1)

  • Survival

    Patient and graft survival ratios

    1 minutes

Secondary Outcomes (4)

  • Perioperative informations

    5 minutes

  • Blood Tests

    15 minutes

  • Postoperative Complications

    5 minutes

  • Postoperative informations

    10 minutes

Study Arms (1)

Pediatric Patients with Liver Transplantation

OTHER
Procedure: Liver Transplantation

Interventions

Liver TransplantationPROCEDURE

Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.

Pediatric Patients with Liver Transplantation

Eligibility Criteria

Age0 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pediatric patients with liver transplantation (\<18 years)

You may not qualify if:

  • Patients with incomplete medical records will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Bahçelievler Hospital

Istanbul, 34700, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Liver DiseasesBiliary Atresia

Interventions

Liver Transplantation

Condition Hierarchy (Ancestors)

Digestive System DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Tissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsDigestive System Surgical ProceduresSurgical Procedures, OperativeOrgan TransplantationTransplantation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr.

Study Record Dates

First Submitted

February 24, 2021

First Posted

March 3, 2021

Study Start

February 24, 2021

Primary Completion

April 1, 2022

Study Completion

April 4, 2022

Last Updated

April 6, 2022

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)